Biotechnology News

October 30, 2012

CARY, N.C.--(BUSINESS WIRE)--ISR surveyed 100 Principal Investigators and Site-coordinators across 11 therapeutic areas to compare the level of compensation paid to investigator sites for participation in a clinical study.

October 30, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Extraordinary General Meeting of Diamyd Medical AB (publ)(STO:DIAMB)(Pink Sheets:DMYDY) held today decided in accordance with the Board's resolution, to approve the agreement to sell all shares in...

October 30, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--US-based drug companies spend an average $237,000 on each of their medical science liaisons (MSLs).

October 30, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of asthma, surveyed physicians’ prescribing practices of LABA/...

October 30, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Class action lawsuits have been filed against Peregrine Pharmaceuticals for alleged violations of U.S. securities laws; owners of Peregrine securities can move to become lead plaintiff by 11/27/12.

October 30, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Announces FDA Acceptance of Two sNDAs for the Use of Latuda as Monotherapy and Adjunctive Therapy in Adult Patients with Depressive Episodes Associated with Bipolar I Disorder

October 30, 2012

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended September 30, 2012. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share,...

October 30, 2012

ROCHESTER, N.Y--(BUSINESS WIRE)--Carestream new lesion management software--just cleared by the FDA--makes it faster and easier for radiologists to measure and compare lesions, as well as tumors and other anatomical structures.

October 30, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Swedish specialty pharmaceutical company Orexo (STO:ORX) today communicated the start of the dose finding study for OX51 in patients undergoing prostate biopsy. Results from the study, which is a...

October 30, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The company’s partner, Intercede has developed the new MyID® CardChecker™ App, compatible with Precise Biometrics’ (STO:PREC) Tactivo™ smart card and fingerprint reader for the iPhone and iPad. With...

October 30, 2012

BISHOPS STORTFORD, England--(BUSINESS WIRE)--Dotmatics Limited, a leading supplier of scientific informatics solutions to the Biotech industry, announces that Spermatech AS, has selected the Dotmatics Platform to manage their scientific data.

October 30, 2012

MILFORD, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the new Thermo Scientific Sorvall LYNX superspeed centrifuge series, delivering productivity, safety and reliability to maximize...

October 30, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today reported third quarter 2012 financial results. Adjusted net income increased $15.3 million to $32.5 million in the third quarter 2012, or $0.48 per diluted share,...

October 30, 2012

DURHAM, N.C.--(BUSINESS WIRE)--Stefan Dürr, Cenduit LLC associate director of project management, will discuss how to avoid the risks of patient or material unblinding when defining drug supply specifications of IRT systems.

October 30, 2012

SEATTLE--(BUSINESS WIRE)--LabConnect, LLC has launched its new service, Scientific Operations Support (SciOps), to offer unique functional outsourcing services to the pharmaceutical research industry.

October 30, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal year ended July 31, 2012 (“fiscal 2012”). Revenue for fiscal 2012...

October 30, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences today announced its third-quarter 2012 financial results.

October 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presents data at Oligo Therapy Society supporting use of TLR antagonists for autoimmune diseases. Idera's TLR antagonist compounds shown to inhibit inflammasome activity in preclinical models.

October 30, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that the Company received two Silver Awards at the annual Medical Marketing & Media (MM&M) Awards ceremony: one for its AMPYRA.com Consumer site in...

October 30, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

October 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced a strategic restructuring designed to optimize resources and reduce expenses to ensure AVEO is well positioned for a successful launch of tivozanib in renal cell...

October 30, 2012

EDINBURGH, Scotland--(BUSINESS WIRE)--TPP Global Development Ltd (TPP) enters into a collaboration with Sprint Bioscience AB to develop small molecule inhibitors of choline kinase as human therapeutics for the treatment of cancer. Under the terms...

October 29, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--Patent for novel coating capable of incorporating multiple pharmaceutical agents, enabling surgically implantable medical devices made from PTFE or ePTFE to also be used as drug-delivery devices.

October 29, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus (NASDAQ:CERS) will postpone its scheduled release date for Q3 financial results from Tuesday, October 30, 2012 to Wednesday, November 7, 2012 due to expected severe weather conditions.

October 29, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for the third quarter ended September 30, 2012, on Monday, November 5, 2012. C. Randal Mills, Ph.D., President and...

October 29, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences will present at the Singular Research 7th Annual "Best of the Uncovereds" Conference on November 1 in Los Angeles, California.

October 29, 2012

TUSTIN, Calif.--(BUSINESS WIRE)--Orange County Research Center (OCRC), founded in 1985, completes the expansion of their Pharmacokinetics Unit (OCRC PK Unit), founded in 2000. The newly redesigned OCRC PK Unit has expanded to 10,000 square feet,...

October 29, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions today announced that it will now release its third quarter 2012 financial results before the open of the market on Wednesday, October 31, 2012 due to severe weather conditions.

October 29, 2012

CINCINNATI, Ohio--(BUSINESS WIRE)--BioRx to distribute second infusion therapy for patients with alpha-1 antitrypsin deficiency.

October 29, 2012

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that, due to the weather-related emergency on the East Coast, the company plans a one-day delay in the release of its third-quarter 2012 financial results....

October 29, 2012

SEATTLE--(BUSINESS WIRE)--October 29, 2012–Dendreon Corporation (Nasdaq: DNDN) today announced that in light of Hurricane Sandy, the Company has rescheduled the release of its third quarter 2012 earnings results. Certain members of its senior...

October 29, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ:CGEN) announced today the postponement of both the issuance of its Third Quarter 2012 Financial Results Report and conference call with investors to Monday, November 5, 2012 at 10 a.m. ET....

October 29, 2012

DURHAM, N.C.--(BUSINESS WIRE)--PharPoint Research was named one of the 50 fastest growing private companies in the Raleigh-Durham area for the second year in the row by the Triangle Business Journal.

October 29, 2012

VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that Lawrence C. Marsh, 52, will join the company in the new role of Chief Strategy Officer and Senior Vice President, New Market Development, effective...

October 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Reschedules its Third Quarter 2012 Financial Results Conference Call and Webcast Due to Hurricane Sandy

October 29, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

October 29, 2012

RICHMOND, Va. & NORFOLK, Va.--(BUSINESS WIRE)--The Environmental Protection Agency Supports Claim that Cupron Enhanced EOS Can Kill 99.9% of Bacteria in Under Two Hours.

October 29, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the total number of diagnosed incident cases of prostate cancer in Russia will...

October 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ensemble poster presentation on orally active small molecule antagonists of Interleukin-17 at American College of Rheumatology (ACR) 2012, November 13, 2012

October 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra CMO, Donna Ambrosino, MD, has been invited to present VIS410 at the Int'l Society for Influenza and Other Respiratory Virus Diseases (isirv) Conference in Hanoi, Viet Nam 10/29-31 2012.

October 29, 2012

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy for the early identification and treatment of cancer, today announced growing demand for and adoption of its Xoft® Axxent®...

October 29, 2012

NEW YORK & LAUSANNE, Switzerland--(BUSINESS WIRE)--Celtic Therapeutics, the global private equity firm focused on novel therapeutic product candidates, announced that Beth P. Hecht has joined as a Partner and Chief Legal and Administrative...

October 29, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex makes significant advances in the field of protein-based vaccine development. Dendritic cell targeted vaccine CDX-1401 elicits robust antibody
and T cell responses. Data at SITC 2012.

October 29, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (OTCBB:ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-...

October 29, 2012

ATLANTA--(BUSINESS WIRE)--Clearside Biomedical Inc. of Atlanta, an ophthalmic pharmaceutical company developing targeted therapeutics for the treatment of sight-threatening diseases, announces its new CFO.

October 29, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ) announced today that it has been granted special permission by The Open Joint Stock Company “Isotope” (Isotope), the authorized subsidiary of Russia’s State Atomic Energy...

October 29, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research presents data on subcutaneous formulation of DPC siRNA delivery system showing unprecedented knockdown without toxicity. Potential leap forward for RNAi therapeutics

October 29, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or...

October 29, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today announced that a per protocol interim safety review on Friday, October 26, 2012, by an independent Data Safety Monitoring Board (DSMB) recommended that GTx continue clinical...